Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser.

Thomas J van Rijssen Elon H C Van DijkPaula ScholzMyrte B BreukinkGreet DijkmanPetrus J H PetersRoula TsonakaJan E E KeunenRobert E MacLarenCarel B HoyngSusan M DownesSascha FauserCamiel J F Boon

Published in: Acta ophthalmologica (2021)

At 20 months after treatment, cCSC patients successfully treated with half-dose PDT are less likely to have recurrences of SRF compared with those successfully treated with HSML. However, functional outcomes did not differ.

Keyphrases

photodynamic therapy
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
high grade
peritoneal dialysis
patient reported outcomes